Connect with Us
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.
Dr. Scott Flanders is currently the Vice President of Medical Affairs at Dendreon Pharmaceuticals LLC, located in Seattle, WA.
Scott has worked over 24 years in the life sciences industry and Medical Affairs area. Before joining Dendreon in 2018, Dr. Flanders was with Astellas Pharma Global Development as the U.S. lead for health economics and outcomes research (HEOR) Oncology group responsible for strategy and execution of HEOR research to include the development of real world research protocols, pharmacoeconomic models, statistical analysis, and global publications.
Scott’s other professional experience includes serving as the Strategic Lead for Health Care Quality and Medical External Affairs and as National Director, Clinical Science and Outcomes Research Field Team, with Takeda Pharmaceuticals; the Associate Director, Regional Outcomes, with Ortho McNeil-Janssen (OMJ) Scientific Affairs; and Sr. Manager of Health Economics, with TAP Pharmaceutical Products Inc.
Scott has a Bachelor of Science degree in Business Administration (Finance) and a Master of Science degree in Health Care Administration from Trinity University, in San Antonio, TX. After working as a licensed Nursing Home Administrator, he received a Doctor of Philosophy degree in Health Services Research (Economic) from Saint Louis University, St. Louis, MO.
Scott lives with his wife in Seattle, Washington. He loves the listen to the Blues and play golf when the weather and time permits.
Dr. João Dias is an honors graduate of the University of Helsinki. He received his Licentiate/MSc in biochemistry from the Universities of Porto, Portugal and Wageningen, the Netherlands; and his PhD studies in Immuno-Oncology and Gene Therapy at Helsinki University Central Hospital and Helsinki University, faculty of Medicine.
He is currently responsible for international medical affairs and clinical development for the medical devices and diagnostics portfolio at Haemonetics which includes Hemostasis Management, Cell Salvage and Transfusion Management products. Prior to this role, João had a variety of roles of increasing responsibility in the areas of both market access and medical marketing.
He has authored several peer-reviewed publications and white papers in the fields of Hemostasis, Patient Blood Management, Immuno-Oncology, Gene Therapy, Hematology, and Molecular Biology.
Prior to his tenure at Haemonetics, João worked as a scientist in the development of new products in Cancer Gene Therapy and served as a Life Sciences Consultant working together with multiple global life-science companies.”
John Pracyk is an executive medical leader with deep expertise in the safe and effective design, development, and commercialization of medical devices. Clinically trained as a Neurological Surgeon he possesses an uncommon blend of business and medical expertise and is a passionate proponent of value-based care and outcomes-driven, evidence-based practices. Dr. Pracyk is a recognized thought leader and program architect in the development of collaborative healthcare delivery platforms with a proven track record of multidisciplinary program buildouts and care redesign successes. A servant leader who motivates high-performing teams to outpace innovation timelines, exceed expectations, and fuel organizational transformation.
Prior to joining Olympus, Dr. Pracyk held multiple leadership roles of increasing responsibility with DePuy Synthes-Spine, Johnson & Johnson Medical Devices. He began his MedTech career in 2016 as Franchise Medical Director where he fostered meaningful innovation to drive safety and value for patients worldwide. There he delivered deep medical and scientific insights to the R&D and commercial teams for product ideation and development, including conceptual, hands-on evaluation, and clinical research perspectives.
In 2017, Dr. Pracyk was tapped to be medically responsible for J&J’s Global Spine Platform as the Franchise Medical Leader leveraging integrated procedural solutions to drive innovation and answer unmet clinical needs. He forged relationships with internal and external stakeholders, including Key Opinion Leaders, practicing surgeons, global regulatory agencies, professional societies, and executive leadership teams from hospitals, health systems, and integrated delivery networks.
In 2018, Dr. Pracyk was appointed Integrated Leader of Preclinical Research, Clinical Research, and Medical Affairs (PCM), a newly integrated scientific platform for Spine. The PCM concept incorporates product development with preclinical and clinical research outcomes and unifies them within the context of Medical Affairs to substantiate safety, performance, and value. Their objective is to ensure that all platform decisions are medically informed, surgically literate, clinically relevant, and financially sustainable. His PCM team’s accomplishments were spotlighted in J&J’s Meet the Innovator series as they got out in front of all goals, condensed timetables to move ahead, and completed the clinical post market clinical follow up plans for the new European Medical Device Regulation a full year ahead of schedule.
Outside of Olympus, Dr. Pracyk is becoming a leading voice in the Medical Affairs Professional Society (MAPS) where he was elected President of the Americas Region, Treasurer of the Executive Committee, and Board Director. MAPS amplifies the individual voices of over 6100 medical professionals that serve patients from within 200+ medical device and pharmaceutical manufacturers. By contextualizing the real-world clinical needs of patients, providers, and policy makers MAPS succinctly translates science into value to deliver a strategically critical scientific perspective in today’s ever-changing global healthcare landscape.
Dr. Pracyk obtained his BS, MD and PhD degrees through the Early Identification and the Medical Scientist Training Programs at Duke University. He was competitively awarded research fellowships at Cambridge University and the National Institutes of Health. He received his Neurological Surgery training at Duke University & The George Washington University and then completed a clinical spine fellowship at the University of Iowa. In 2015, he obtained a healthcare focused MBA at the Haslam College of Business of The University of Tennessee. Dr. Pracyk is a Fellow of the American Association of Neurological Surgeons and the American College of Surgeons, as well as a Diplomate of the American Board of Neurological Surgery. He maintains active memberships in the Medical Affairs Professional Society, American Association of Neurological Surgeons, Congress of Neurological Surgeons, North American Spine Society, AO Spine, Phi Kappa Phi, and the American College of Healthcare Executives.
April Adams, PharmD, Senior Director of US CV Field Team for Bristol Myers Squibb is a focused and strategically driven leader in Medical Affairs with over 21 years of experience in the pharmaceutical industry. Her past roles include being an MSL, an MSL Regional Director, and Global Director for Field Medical Excellence. During her career she has built and led many field teams supporting different therapy areas including oncology, respiratory, neuroscience, cardiovascular, rheumatology, and pain management. Her passion is working to ensure the impact and value of the field medical team through actionable medical insights.
April received her PharmD degree from Mercer University Southern School of Pharmacy and Bachelor of Pharmacy Arts from David Lipscomb University. Upon graduating from pharmacy school, she spent 9 years working in pediatrics, long term care, general medicine and academia. She is a registered pharmacist in the state of Georgia where she has lived since 1987. She and her husband, Bryan, have been married for 31 years and have two daughters.
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.